Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -75.46% is 84% above its 5-year average of -463.28%, near the high end of its 5-year range (-1780.96%–19.12%).
2.89% below its 12-month average of -73.34%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -52.59%.
EBITDA MARGIN
-75.46%
EBITDA MARGIN AVG TTM
-73.34%
EBITDA MARGIN AVG 3Y
-76.58%
EBITDA MARGIN AVG 5Y
-463.28%
EBITDA MARGIN AVG 10Y
-439.90%
EBITDA MARGIN AVG 15Y
-517.55%
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-2.89%
CURRENT VS 3Y AVG
+1.46%
CURRENT VS 5Y AVG
+83.71%
CURRENT VS 10Y AVG
+82.85%
CURRENT VS 15Y AVG
+85.42%
CURRENT VS 20Y AVG
N/A
INVO Fertility, Inc.
Market Cap
$1.45M
EBITDA Margin
-75.46%
TTM Avg
-73.34%
3Y Avg
-76.58%
5Y Avg
-463.28%
Market Cap
$1.46M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.47M
EBITDA Margin
-346.64%
TTM Avg
-376.56%
3Y Avg
-438.06%
5Y Avg
-395.70%
Market Cap
$1.47M
EBITDA Margin
-1231.39%
TTM Avg
-651.84%
3Y Avg
-512.06%
5Y Avg
-24032.93%
Market Cap
$1.16M
EBITDA Margin
-17.60%
TTM Avg
-16.25%
3Y Avg
-23.94%
5Y Avg
-32.10%
Market Cap
$1.18M
EBITDA Margin
-40873.19%
TTM Avg
-40873.19%
3Y Avg
-21172.28%
5Y Avg
-10780.34%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| INVO Fertility, Inc. (IVF) | $1.45M | -75.46% | -73.34% | -76.58% | -463.28% |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.46M | N/A | N/A | N/A | N/A |
| Curis, Inc. (CRIS)vs › | $1.47M | -346.64% | -376.56% | -438.06% | -395.70% |
| PMGC Holdings Inc. (ELAB)vs › | $1.47M | -1231.39% | -651.84% | -512.06% | -24032.93% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.40M | N/A | N/A | N/A | N/A |
| NewcelX Ltd. (NCEL)vs › | $1.39M | N/A | N/A | N/A | N/A |
| Genprex, Inc. (GNPX)vs › | $1.31M | N/A | N/A | N/A | N/A |
| IM Cannabis Corp. (IMCC)vs › | $1.16M | -17.60% | -16.25% | -23.94% | -32.10% |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.18M | -40873.19% | -40873.19% | -21172.28% | -10780.34% |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.10M | -6.76% | -0.42% | 7.09% | 7.09% |
Gross Margin
33.3%
EBITDA Margin
-75.5%
Operating Margin
-78.7%
Net Margin
-70.2%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -52.59% |
| 2026-03-31 | -71.87% |
| 2025-12-31 | -80.58% |
| 2025-09-30 | -85.30% |
| 2025-06-30 | -76.36% |
| 2025-03-31 | -136.08% |
| 2024-12-31 | -222.07% |
| 2024-09-30 | -74.65% |
| 2024-06-30 | -91.07% |
| 2024-03-31 | -45.64% |
| 2023-12-31 | -98.92% |
| 2023-09-30 | -88.81% |
| 2023-06-30 | -647.76% |
| 2023-03-31 | -657.23% |
| 2022-12-31 | -949.43% |
| 2022-09-30 | -1064.79% |
| 2022-06-30 | -1780.96% |
| 2022-03-31 | -1616.56% |
| 2021-12-31 | 19.12% |
| 2021-09-30 | -1017.62% |
| 2021-06-30 | -889.76% |
| 2021-03-31 | -226.60% |
| 2020-12-31 | -905.08% |
| 2020-09-30 | -374.61% |
| 2020-06-30 | -428.48% |
| 2020-03-31 | -536.80% |
| 2019-12-31 | -222.68% |
| 2019-09-30 | -205.31% |
| 2019-06-30 | -9.21% |
| 2019-03-31 | -183.25% |
| 2018-12-31 | -330.29% |
| 2018-09-30 | -150.75% |
| 2018-06-30 | -1623.55% |
| 2018-03-31 | -133.62% |
| 2017-12-31 | -240.46% |
| 2017-09-30 | -209.43% |
| 2017-06-30 | -164.84% |
| 2017-03-31 | -319.11% |
| 2016-12-31 | -2840.13% |
| 2016-09-30 | -1162.99% |
| 2016-06-30 | -26654.68% |
| 2016-03-31 | -989.98% |
| 2015-09-30 | -4669.96% |
| 2015-06-30 | -1910.14% |
| 2015-03-31 | -3598.18% |
| 2011-12-31 | -3960.29% |
| 2011-09-30 | -1312.13% |
| 2011-06-30 | -886.32% |
| 2011-03-31 | -516.08% |
| 2010-12-31 | -1378.29% |
| 2010-06-30 | -2743.55% |
| 2010-03-31 | -1583.22% |
| 2009-12-31 | -6739.91% |
| 2009-09-30 | -10200.11% |
| 2009-06-30 | -2586.53% |
| 2009-03-31 | -1744.38% |
